# FDA recall D-1063-2014

> **Forest Pharmaceuticals Inc** · Class III · drug recall initiated 2013-11-13.

## Product

Namenda XR (memantine HCl), 7 mg extended release capsules, 30-count bottle, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045, NDC 0456-3407-33

## Reason for recall

Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.

## Distribution

Nationwide and Puerto Rico.

## Key facts

- **Recall number:** D-1063-2014
- **Recalling firm:** Forest Pharmaceuticals Inc
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-11-13
- **Report date:** 2014-02-12
- **Termination date:** 2014-05-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Earth City, MO, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1063-2014

## Citation

> AI Analytics. FDA recall D-1063-2014. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-1063-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*